The latest price target for Werewolf Therapeutics (NASDAQ:HOWL) was reported by HC Wainwright & Co. on December 19, 2025. The analyst firm set a price target for $4.00 expecting HOWL to rise to within ...

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Fintel reports that on May 12, 2023, B of A Securities maintained coverage of Werewolf Therapeutics (NASDAQ:HOWL) with a Buy recommendation. As of May 11, 2023, the average one-year price target for ...

Werewolf Therapeutics, Inc. (HOWL) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.14 per share a year ago. These ...